These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6201487)

  • 1. Defects of axonal transport in diabetes mellitus--a possible contribution to the aetiology of diabetic neuropathy.
    Tomlinson DR; Mayer JH
    J Auton Pharmacol; 1984 Mar; 4(1):59-72. PubMed ID: 6201487
    [No Abstract]   [Full Text] [Related]  

  • 2. Axonal transport and nerve conduction velocity in animal models of diabetic neuropathy.
    Tomlinson DR; Mayer JH
    Diabet Med; 1985 May; 2(3):210-2. PubMed ID: 2952422
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
    Mayer JH; Tomlinson DR
    Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy?
    Greene DA; Lattimer SA; Sima AA
    Diabetes; 1988 Jun; 37(6):688-93. PubMed ID: 2838351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyols and myo-inositol in diabetic neuropathy--of mice and men.
    Tomlinson DR
    Mayo Clin Proc; 1989 Aug; 64(8):1030-3. PubMed ID: 2796398
    [No Abstract]   [Full Text] [Related]  

  • 6. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy.
    Dyck PJ; Zimmerman BR; Vilen TH; Minnerath SR; Karnes JL; Yao JK; Poduslo JF
    N Engl J Med; 1988 Sep; 319(9):542-8. PubMed ID: 3136330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered sorbitol and myo-inositol metabolism as the basis for defective protein kinase C and (Na,K)-ATPase regulation in diabetic neuropathy.
    Greene DA; Lattimer SA
    Ann N Y Acad Sci; 1986; 488():334-40. PubMed ID: 3034118
    [No Abstract]   [Full Text] [Related]  

  • 8. The biochemistry of the complications of diabetes mellitus.
    Brownlee M; Cerami A
    Annu Rev Biochem; 1981; 50():385-432. PubMed ID: 6168237
    [No Abstract]   [Full Text] [Related]  

  • 9. Essential fatty acid treatment--effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats.
    Tomlinson DR; Robinson JP; Compton AM; Keen P
    Diabetologia; 1989 Sep; 32(9):655-9. PubMed ID: 2477293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic correlates and axonal transport in nerves during experimental diabetes.
    Alberghina M
    Metab Pediatr Syst Ophthalmol (1985); 1986; 9(2-4):42-6. PubMed ID: 2454383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism.
    Greene DA; Lattimer-Greene S; Sima AA
    Crit Rev Neurobiol; 1989; 5(2):143-219. PubMed ID: 2561904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
    Tomlinson DR; Moriarty RJ; Mayer JH
    Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogenesis of diabetic neuropathies].
    Lalau JD; Arlot S; Quichaud J
    Ann Med Interne (Paris); 1985; 136(6):486-95. PubMed ID: 3909874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy.
    Finegold D; Lattimer SA; Nolle S; Bernstein M; Greene DA
    Diabetes; 1983 Nov; 32(11):988-92. PubMed ID: 6416910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alterations in the sorbitol pathway and Na(+)-K(+)-ATPase activity of peripheral nerve of alloxan-induced diabetic rats].
    Lu KM; Zhong XL; Zhu XX; Zhu QY
    Sheng Li Xue Bao; 1990 Aug; 42(4):401-5. PubMed ID: 2175949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat.
    Stevens MJ; Lattimer SA; Kamijo M; Van Huysen C; Sima AA; Greene DA
    Diabetologia; 1993 Jul; 36(7):608-14. PubMed ID: 8359577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
    Shindo H; Tawata M; Aida K; Onaya T
    J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diabetic neuropathy--a review of pathological studies].
    Kito S; Yamamura Y
    Nihon Rinsho; 1991 Feb; 49 Suppl():152-8. PubMed ID: 1851895
    [No Abstract]   [Full Text] [Related]  

  • 19. Sorbitol, myo-inositol and sodium-potassium ATPase in diabetic peripheral nerve.
    Greene DA
    Drugs; 1986; 32 Suppl 2():6-14. PubMed ID: 3024950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axonal transport and nerve conduction and their relation to nerve polyol and myo-inositol levels in spontaneously diabetic BB/D rats.
    Mayer JH; Herberg L; Tomlinson DR
    Neurochem Pathol; 1984-1985 Winter; 2(4):285-93. PubMed ID: 6085698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.